85 related articles for article (PubMed ID: 27446364)
1. Evaluation of 3D-CPA, HR-HPV, and TCT joint detection on cervical disease screening.
Liang H; Fu M; Zhou J; Song L
Oncol Lett; 2016 Aug; 12(2):887-892. PubMed ID: 27446364
[TBL] [Abstract][Full Text] [Related]
2. [Value assessment of high-risk HPV test and TCT in the screening of cervical carcinoma].
Sun XF; Gu YQ; Wang AC; Wang J; Xie JL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Aug; 27(4):273-6. PubMed ID: 24579473
[TBL] [Abstract][Full Text] [Related]
3. Value of TCT combined with HPV and CA125 in early cervical cancer screening in a medical examination population.
Xiao M; Zhang Z; Yu X; Fan Y; Chen X
Cell Mol Biol (Noisy-le-grand); 2022 Sep; 68(9):160-164. PubMed ID: 36905257
[TBL] [Abstract][Full Text] [Related]
4. ThinPrep cytologic test combined with HPV typing to evaluate the degree of cervical diseases and the relationship between HPV typing and the pathological results of patients with atypical squamous cells of undetermined significance: a diagnostic test.
Wang L; Song Q; Liu Y; Ou Q
Transl Cancer Res; 2022 Sep; 11(9):3277-3286. PubMed ID: 36237241
[TBL] [Abstract][Full Text] [Related]
5. Genomic amplification of HPV, h-TERC and c-MYC in liquid-based cytological specimens for screening of cervical intraepithelial neoplasia and cancer.
Ji W; Lou W; Hong Z; Qiu L; Di W
Oncol Lett; 2019 Feb; 17(2):2099-2106. PubMed ID: 30675277
[TBL] [Abstract][Full Text] [Related]
6. [Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China].
Li LY; Qiao ZQ; Zhang MF; Yang JP; Bao YP; An YT; Lei J; Xiong NH; Yu XH; Zhang X; Pan QJ; Qiao YL
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):964-7. PubMed ID: 18399140
[TBL] [Abstract][Full Text] [Related]
7. Detection of HPV E6/E7 mRNA in the diagnosis of cervical cancer and precancerous lesions after kidney transplantation.
Sun J; Yue Y; Li R; Sun Q; Hu C; Ge X; Guan Q
Am J Transl Res; 2021; 13(6):7312-7317. PubMed ID: 34306499
[TBL] [Abstract][Full Text] [Related]
8. An efficient method that combines the ThinPrep cytologic test with E6/E7 mRNA testing for cervical cancer screening.
Pan D; Zhang CQ; Liang QL; Hong XC
Cancer Manag Res; 2019; 11():4773-4780. PubMed ID: 31213899
[No Abstract] [Full Text] [Related]
9. Epidemiological study of high-risk human papillomavirus infection in subjects with abnormal cytological findings in cervical cancer screening.
You W; Li S; Du R; Zheng J; Shen A
Exp Ther Med; 2018 Jan; 15(1):412-418. PubMed ID: 29375696
[TBL] [Abstract][Full Text] [Related]
10. Transvaginal three-dimensional color power Doppler ultrasound and cervical MVD measurement in the detection of cervical intraepithelial neoplasia.
Liang H; Fu M; Liu FM; Song L; Li P; Zhou J
Eur Rev Med Pharmacol Sci; 2014; 18(14):1979-84. PubMed ID: 25027335
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for human papillomavirus infection in Shanghai suburbs: a population-based study with 10,000 women.
Zhang R; Shi TY; Ren Y; Lu H; Wei ZH; Hou WJ; Zhang M; Xu C
J Clin Virol; 2013 Sep; 58(1):144-8. PubMed ID: 23849649
[TBL] [Abstract][Full Text] [Related]
12. [Clinical analysis of cervical intraepithelial lesion in postmenopausal women].
Zhang X; Guan XJ; Li JQ; Zhang LH; Yang JH
Zhonghua Fu Chan Ke Za Zhi; 2018 Oct; 53(10):705-710. PubMed ID: 30369128
[No Abstract] [Full Text] [Related]
13. Clinical utility of HPV typing and quantification combined with PAX1/ZNF582 methylation detection in accurate cervical cancer screening.
Wen Y; Liang H; Zhang H
Cytojournal; 2023; 20():26. PubMed ID: 37681081
[TBL] [Abstract][Full Text] [Related]
14. [The study of combining high-risk human papillomavirus types checking and cytologic test in the screening of cervical lesions].
Xu XH; Xie ZX; Ma R; Zhang WQ; Li QF
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Aug; 25(4):298-300. PubMed ID: 22097613
[TBL] [Abstract][Full Text] [Related]
15. High-risk human papillomavirus detection in women with low-grade squamous intraepithelial lesions or higher-grade cytology using the Cervista HPV HR test.
Gold MA; Thomas MA; Huh WK; Sarto GE; Day SP
J Low Genit Tract Dis; 2013 Jan; 17(1):51-7. PubMed ID: 22885641
[TBL] [Abstract][Full Text] [Related]
16. [An optoelectronic cervical cancer screening system for screening cervical cancer: comparison with cervical cytology].
He XK; Luo XP; Mao LZ; Chen GY; Li Y; Zhang JY
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Oct; 30(10):2304-6. PubMed ID: 20965832
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic accuracy of TCT + HPV-DNA for cervical cancer: systematic review and meta-analysis.
Li T; Lai Y; Yuan J
Ann Transl Med; 2022 Jul; 10(14):761. PubMed ID: 35965790
[TBL] [Abstract][Full Text] [Related]
18. E6/E7 proteins are potential markers for the screening and diagnosis of cervical pre-cancerous lesions and cervical cancer in a Chinese population.
Shi WJ; Liu H; Wu D; Tang ZH; Shen YC; Guo L
Oncol Lett; 2017 Nov; 14(5):6251-6258. PubMed ID: 29113275
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
